Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy

Apar Pataer(The University of Texas MD Anderson Cancer Center), Neda Kalhor(The University of Texas MD Anderson Cancer Center), Arlene M. Correa(The University of Texas MD Anderson Cancer Center), Maria Gabriela Raso(The University of Texas MD Anderson Cancer Center), Jeremy J. Erasmus(The University of Texas MD Anderson Cancer Center), Edward S. Kim(The University of Texas MD Anderson Cancer Center), Carmen Behrens(The University of Texas MD Anderson Cancer Center), J. Jack Lee(The University of Texas MD Anderson Cancer Center), Jack A. Roth(The University of Texas MD Anderson Cancer Center), David J. Stewart(The University of Texas MD Anderson Cancer Center), Ara A. Vaporciyan(The University of Texas MD Anderson Cancer Center), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Stephen G. Swisher(The University of Texas MD Anderson Cancer Center)
Journal of Thoracic Oncology
April 5, 2012
Cited by 360Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis